Sulfa drugs elicit neurological adverse effects because they interfere with L-3,4-dihydroxyphenylalanine synthesis
Sulfa Drugs: What’s Behind Their Neurological Side Effects?
From Pharmacy to the Pub — A Bark Conquers the World: Part 2
Thomas Buchler, CEO of the quinine producer Buchler & Co., talks about the ups and downs of the international cinchona trade
Uwe Bornscheuer on Biocatalysis and Publishing
Professor Uwe Bornscheuer talks about his exciting field of research, biocatalysis and protein engineering, and his broad experience in publishing
Drug Against Ovarian Burnout
The immune drug AS10 protects the ovaries from the toxic effects exerted by the chemotherapeutic agent cyclophosphamide
Fooling Toxins with Mimetic Nanosponges
Poly(lactic-co-glycolic acid) nanoparticles wrapped with red blood cell membranes neutralize pore-forming toxins
A Drug Discovery Detective Story
Biological activity of small-molecule RNA polymerase (RNAP) inhibitors revealed to come from polymeric impurity
Most Accessed Articles: April 2013
The most-accessed chemistry articles from ChemPubSoc Europe and GDCh journals for April 2013
Frances Arnold Awarded Emanuel Merck Lectureship 2013
Professor Frances Arnold, Caltech, USA, has been awarded the Emanuel Merck Lectureship and will deliver a special public lecture
Meat, Bacteria, and Atherosclerosis
By metabolizing L-carnitine, a nutrient abundant in red meat, intestinal bacteria promote atherosclerosis
Discovery of Unexpectedly Active Group
Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off